Roundup: Missouri court approves settlement worth up to $7.25 billion
The approval concerns US weedkiller litigation. It remains subject to appeal and does not mean the entire amount will be paid immediately.

A Missouri judge approved Bayer’s settlement of lawsuits linking Roundup to cancer on 20 November, Reuters reported. The programme addresses existing and future US claims alleging non-Hodgkin lymphoma injuries following exposure to the weedkiller.
Bayer announced that Monsanto will fund the settlement through declining capped annual payments for up to 21 years. The maximum total is $7.25 billion, including payments already made. This is a funding ceiling over time, rather than a new one-off cash payment.
The company says the final approval order remains subject to appeal. Any appeal would pause further Monsanto payments until the appeals process is exhausted. Approval at this stage therefore does not amount to a final, unappealable resolution.
Reuters reports that supporters view the agreement as a route to compensation, while opponents challenge the adequacy of the amounts and restrictions on pursuing lawsuits. These are the positions of parties to the dispute.
English translation of the Greek edition · Read in Greek